Mycomax (Fluconazole)

Fluconazole, the active ingredient in Mycomax, is an azole antifungal presented as an oral tablet for systemic use. It treats a range of fungal infections, including candidiasis, cryptococcal meningitis and dermatophyte infections, and is prescribed for adult and pediatric patients under medical supervision. The drug is absorbed well after oral administration and achieves therapeutic concentrations in blood and tissues.

GNH USA supplies Mycomax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Fluconazole is an azole antifungal that targets systemic and mucosal fungal infections. - Candidiasis: effective for oral, esophageal and vaginal infections, reducing fungal load and alleviating symptoms. - Cryptococcal meningitis: used in combination therapy to eradicate Cryptococcus neoformans from the central nervous system. - Dermatophyte infections: treats skin and nail infections caused by Trichophyton, Microsporum and Epidermophyton species. - Invasive candidiasis: administered intravenously (when formulated) to treat bloodstream infections and deep‑tissue candidiasis.

Fluconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often reported. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort in the stomach area. - Diarrhea: loose stools without blood. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient increase in hepatic transaminases. - Dizziness: feeling of lightheadedness or unsteadiness. - Taste disturbance: altered perception of flavors.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, jaundice or hepatitis. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Anaphylaxis: acute allergic reaction with airway compromise. - Severe neutropenia: marked reduction in white blood cells. - Cardiac arrhythmias: QT prolongation leading to irregular heartbeat.

Before prescribing fluconazole, clinicians should consider several precautionary measures to ensure patient safety. - Assess liver function: obtain baseline hepatic enzyme tests and monitor periodically. - Evaluate renal function: adjust dose in patients with severe renal impairment. - Review concomitant medications: avoid or monitor drugs that may interact adversely. - Screen for hypersensitivity: discontinue if rash or anaphylaxis occurs. - Pregnancy and lactation: weigh potential risks as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Fluconazole interacts with several medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Rifampin: induces metabolism, markedly reducing fluconazole levels. - Terbinafine: combined use increases risk of hepatotoxicity. - Phenytoin: accelerates clearance, lowering antifungal efficacy. - Azole‑azole combinations: additive toxicity, especially hepatic.

Moderate Interactions (Monitor Closely): - Warfarin: fluconazole may increase INR, requiring dose adjustment. - Oral contraceptives: reduced estrogen levels may diminish contraceptive effectiveness. - Cyclosporine: increased blood concentrations may lead to nephrotoxicity. - Statins (e.g., simvastatin): higher risk of myopathy, monitor muscle symptoms.